Organization

NeuroPro Therapeutics

1 clinical trial

Clinical trial

A Single-center, Randomized, Placebo Controlled, Double-blind, Ascending Single-dose and Repeated-dose Trial to Determine the Safety and Pharmacokinetic Profile of NPT 2042 Soft-Gelatin Capsules Administered Orally to Healthy Adult Subjects

Status: Completed, Estimated PCD: 2023-03-17